Page last updated: 2024-08-21

pyrazines and Chronic Kidney Failure

pyrazines has been researched along with Chronic Kidney Failure in 49 studies

Research

Studies (49)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (12.24)	18.7374
1990's	2 (4.08)	18.2507
2000's	13 (26.53)	29.6817
2010's	26 (53.06)	24.3611
2020's	2 (4.08)	2.80

Authors

Authors	Studies
Kosuru, R; Prakash, S; Rai, U; Singh, S; Tiwari, V	1
Goto, Y; Hiraiwa, H; Ishimoto, T; Jingushi, N; Kato, I; Koshi, E; Kosugi, T; Maruyama, S; Miyagawa, Y; Numaguchi, A; Okazaki, M; Ozaki, M; Saito, S; Tetsuka, N; Toyama, Y; Yagi, T; Yamamoto, T	1
Myers, R; Tollkuci, E; Tran, T	1
Schütt, M; Steinhoff, J; Süfke, S	1
Åsberg, A; Hartmann, A; Jenssen, T; Strøm Halden, TA; Vik, K	1
Alloway, RR; Cardi, MA; Krisl, JC; Shields, AR; Woodle, ES	1
Christensen, M; Feldt-Rasmussen, B; Holst, JJ; Hornum, M; Idorn, T; Jørgensen, MB; Knop, FK	1
Leffell, MS; Montgomery, RA; Philogene, MC; Sikorski, P; Zachary, AA	1
Butani, L; Gallay, B; Nguyen, S	1
de Zoysa, JR; Hutchison, CA; Lam-Po-Tang, M; Tan, J	1
Marks, SD	1
Beimler, J; Breitkreutz, I; Egerer, G; Goldschmidt, H; Heiss, C; Ho, AD; Jäger, D; Neben, K; Perne, A; Raab, MS; Zeier, M	1
Huh, KH; Jeong, HJ; Kim, BS; Kim, YS; Lee, J; Lee, JG; Lim, BJ; Park, Y	1
Caravita, T; de Fabritiis, P; Dentamaro, T; Perrotti, A; Siniscalchi, A; Tatangelo, P	1
Cherem, L; Kahan, BD; Kaposztas, Z; Katz, SM; Van Buren, CT	1
Beksac, M; Bladé, J; Boccadoro, M; Cavenagh, J; Cavo, M; Dimopoulos, M; Drach, J; Einsele, H; Facon, T; Goldschmidt, H; Harousseau, JL; Hess, U; Ketterer, N; Kropff, M; Ludwig, H; Mendeleeva, L; Morgan, G; Palumbo, A; Plesner, T; San Miguel, J; Shpilberg, O; Sondergeld, P; Sonneveld, P; Zweegman, S	1
Alloway, RR; Arend, LJ; Brailey, P; Everly, JJ; Govil, A; Mogilishetty, G; Rike, AH; Roy-Chaudhury, P; Walsh, RC; Woodle, ES	1
Cavo, M	1
Abdellatif, A; Achkar, K; Dilioglou, S; Gaber, AO; Jeroudi, A; Knight, R; Land, G; Patel, S; Raghavan, R; Suki, W	1
Pavlakis, M	1
Abbadie, O; Blanchol, G; Brouard, S; Cantarovich, D; Cesbron, A; Dantal, J; Giral, M; Gosselin, M; Hourmant, M; Lino, M; Mai, HL; Meurette, A; Soulillou, JP	1
Dagher, NN; Lonze, BE; Montgomery, RA; Segev, DL; Simpkins, CE; Singer, AL; Zachary, AA	1
Al Meshari, K	1
Birkenbach, M; Constantinescu, S; Daller, JA; Gillespie, A; Karachristos, A; Lee, I; Leech, S; Sifontis, NM; Silva, P; Swami, A	1
Basu, A; Lunz, J; Mapara, M; Morgan, C; Randhawa, P; Shapiro, R; Sharma, V; Tan, HP; Zeevi, A	1
Cook, WJ; Elkins, S; Gaston, RS; Kumar, V; Prendergast, MB; Reddy, V; Sanders, PW	1
Barth, RN; Cooper, M; Gurk-Turner, C; Hurley, H; KuKuruga, D; Manitpisitkul, W; Philosophe, B; Rasetto, F; Wilson, N	1
Boothpur, R; Brennan, DC; Torrence, S	1
Dagher, NN; Locke, JE; Lonze, BE; Montgomery, RA; Segev, DL; Simpkins, CE; Singer, AL; Zachary, AA	1
Abraham, J; Bridoux, F; Delbès, S; Desport, E; Fermand, JP; Jaccard, A; Lacotte-Thierry, L; Moumas, E; Touchard, G	1
Abraham, J; Bridoux, F; Debiais, C; Delbès, S; Desport, E; Fermand, JP; Hanf, W; Jaccard, A; Lacotte-Thierry, L; Moumas, E; Touchard, G	1
Bacovsky, J; Lochman, P; Minarik, J; Pika, T; Scudla, V; Tichy, T; Zadrazil, J	1
Gertz, MA	1
Alter, M; Chaykovska, L; Fuchs, H; Heiden, S; Hocher, B; Klein, T; Rahnenführer, J; Runge, F; von Websky, K	1
Hussain, SM; Jasnosz, KM; Khan, AS; Ko, TY; Marcus, RJ; Parris, G; Sureshkumar, KK; Thai, NL; Tom, K; Vivas, CA	1
Jimenez-Zepeda, VH	1
Borja-Cacho, D; Chinnakotla, S; Dunn, TB; Finger, E; Kandaswamy, R; Kim, Y; Krefting, P; Manivel, C; Matas, A; Maurer, D; Noreen, H; Pruett, T; Tamayo, G; Verghese, P	1
Cavenagh, J; Cook, G; Cook, M; Davies, F; Elliott, P; Gumbleton, T; Jacobson, E; Oakervee, H; Plesner, T; Popat, R	1
Arjona Ferreira, JC; Corry, D; Davies, MJ; Goldstein, BJ; Golm, GT; Gonzalez, EJ; Kaufman, KD; Mogensen, CE; Sloan, L; Xu, L	1
Anagnostopoulos, A; Bamias, A; Barmparousi, D; Dimopoulos, MA; Gika, D; Grapsa, I; Kastritis, E; Matsouka, C; Psimenou, E; Roussou, M	1
Jensen, HA; Olsen, ME	1
Barrera, E; Barrera, LA; Creparula, R; Gotlieb, D; Pertzov, G; Prigollini, D; Yeyati, NL	1
George, CF	1
Ahsan, N; Beyer, KH; Korsunsky, Z; Vesell, ES	1
Cao, WF; Chen, BX; Li, RH	1
Weinman, EJ	1
Knauf, H; Mutschler, E; Reuter, K	1
Grayer, D; Iber, F	1

Reviews

7 review(s) available for pyrazines and Chronic Kidney Failure

Article	Year
Current multiple myeloma treatment strategies with novel agents: a European perspective. The oncologist, 2010, Volume: 15, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Chromosome Aberrations; Clinical Trials as Topic; Decision Making; Decision Trees; Humans; Kidney Failure, Chronic; Lenalidomide; Multiple Myeloma; Neoplasm Recurrence, Local; Pyrazines; Stem Cell Transplantation; Thalidomide; Transplantation, Homologous	2010
Current status of bortezomib in the treatment of multiple myeloma. Current hematologic malignancy reports, 2007, Volume: 2, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boronic Acids; Bortezomib; Cell Line, Tumor; Clinical Trials as Topic; Combined Modality Therapy; Cytokines; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; Kidney Failure, Chronic; Multicenter Studies as Topic; Multiple Myeloma; Neoplasm Proteins; NF-kappa B; Protease Inhibitors; Proteasome Inhibitors; Pyrazines; Salvage Therapy; Stem Cell Transplantation; Stromal Cells; Transplantation, Autologous	2007
[Current treatment of AL amyloidosis]. Nephrologie & therapeutique, 2011, Volume: 7, Issue:6 Topics: Amyloid; Amyloidosis; Biomarkers; Boronic Acids; Bortezomib; Cardiomyopathies; Consensus Development Conferences as Topic; Dexamethasone; Drug Therapy, Combination; Heart Transplantation; Humans; Immunoglobulin Light Chains; Kaplan-Meier Estimate; Kidney Failure, Chronic; Kidney Transplantation; Lenalidomide; Melphalan; Natriuretic Peptide, Brain; Paraproteinemias; Paraproteins; Peptide Fragments; Prognosis; Pyrazines; Randomized Controlled Trials as Topic; Renal Dialysis; Thalidomide	2011
[New insights in the treatment of myeloma with renal failure]. Nephrologie & therapeutique, 2011, Volume: 7, Issue:6 Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Clinical Trials as Topic; Contraindications; Cyclophosphamide; Dexamethasone; Fluid Therapy; Humans; Hypercalcemia; Immunoglobulin Light Chains; Kidney Failure, Chronic; Lenalidomide; Melphalan; Multicenter Studies as Topic; Multiple Myeloma; Myeloma Proteins; Prospective Studies; Protease Inhibitors; Pyrazines; Randomized Controlled Trials as Topic; Renal Dialysis; Thalidomide	2011
Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation. Clinical nephrology, 2012, Volume: 77, Issue:3 Topics: Adult; Biopsy; Boronic Acids; Bortezomib; Female; Graft Rejection; Humans; Isoantibodies; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Severity of Illness Index; Treatment Outcome	2012
Light chain deposition disease: novel biological insights and treatment advances. International journal of laboratory hematology, 2012, Volume: 34, Issue:4 Topics: Boronic Acids; Bortezomib; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin Light Chains; Kidney Failure, Chronic; Male; Middle Aged; Multiple Organ Failure; Pyrazines	2012
[Status quo of experimental and clinical studies in retarding kidney damage of chronic nephropathy by ligustrazine]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 1997, Volume: 17, Issue:5 Topics: Animals; Calcium Channel Blockers; Free Radical Scavengers; Glomerulosclerosis, Focal Segmental; Humans; Kidney Failure, Chronic; Platelet Aggregation Inhibitors; Pyrazines	1997

Trials

6 trial(s) available for pyrazines and Chronic Kidney Failure

Article	Year
Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014, Volume: 29, Issue:4 Topics: Aged; Blood Glucose; Cross-Over Studies; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Postprandial Period; Prospective Studies; Pyrazines; Risk Factors; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles	2014
Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease. The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:7 Topics: Adult; Blood Glucose; Denmark; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fasting; Female; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Humans; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Peptide Fragments; Proteolysis; Pyrazines; Renal Dialysis; Sitagliptin Phosphate; Triazoles	2014
A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma. British journal of haematology, 2013, Volume: 160, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Creatinine; Dehydration; Drug Resistance, Neoplasm; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Multiple Myeloma; Pyrazines; Recurrence; Remission Induction; Resveratrol; Salvage Therapy; Stilbenes; Treatment Failure; Vomiting	2013
Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trial. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2013, Volume: 61, Issue:4 Topics: Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Glycated Hemoglobin; Humans; Kidney Failure, Chronic; Pyrazines; Renal Dialysis; Sitagliptin Phosphate; Triazoles	2013
Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents. Haematologica, 2007, Volume: 92, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bence Jones Protein; Boronic Acids; Bortezomib; Dexamethasone; Doxorubicin; Female; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloma Proteins; Proteinuria; Pyrazines; Thalidomide; Treatment Outcome; Vincristine	2007
Pyrazinoylguanidine in end-stage renal disease: a prospective, placebo-controlled pilot study. Pharmacology, 1998, Volume: 57, Issue:2 Topics: Administration, Oral; Adult; Blood Glucose; Cholesterol; Female; Guanidines; Humans; Hyperglycemia; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Pyrazines; Renal Dialysis; Triglycerides	1998

Other Studies

36 other study(ies) available for pyrazines and Chronic Kidney Failure

Article	Year
Tetramethylpyrazine alleviates diabetic nephropathy through the activation of Akt signalling pathway in rats. European journal of pharmacology, 2019, Dec-15, Volume: 865 Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Kidney; Kidney Failure, Chronic; Male; Oxidative Stress; Protective Agents; Proto-Oncogene Proteins c-akt; Pyrazines; Rats, Wistar; Signal Transduction	2019
Efficacy of favipiravir for an end stage renal disease patient on maintenance hemodialysis infected with novel coronavirus disease 2019. CEN case reports, 2021, Volume: 10, Issue:1 Topics: Amides; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Female; Humans; Kidney Failure, Chronic; Middle Aged; Pandemics; Positive-Pressure Respiration; Pyrazines; Renal Dialysis; SARS-CoV-2	2021
Gilteritinib administration in a hemodialysis patient. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021, Volume: 27, Issue:5 Topics: Aged; Aniline Compounds; Female; Humans; Kidney Failure, Chronic; Leukemia, Myeloid, Acute; Mutation; Protein Kinase Inhibitors; Pyrazines; Recurrence; Renal Dialysis	2021
[Diabetes treatment in patients with chronic kidney disease]. Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:21 Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Substitution; Drug Therapy, Combination; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Kidney Failure, Chronic; Kidney Function Tests; Male; Metformin; Pyrazines; Sitagliptin Phosphate; Triazoles	2013
Bortezomib-based antibody-mediated rejection therapy and simultaneous conversion to belatacept. Transplantation, 2014, Feb-27, Volume: 97, Issue:4 Topics: Abatacept; Adult; Azathioprine; Biopsy; Boronic Acids; Bortezomib; Calcineurin Inhibitors; Cyclosporine; Glomerulonephritis, IGA; Graft Rejection; Humans; Immunoconjugates; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Diseases; Kidney Failure, Chronic; Kidney Transplantation; Male; Prednisone; Pyrazines; Treatment Outcome	2014
Differential effect of bortezomib on HLA class I and class II antibody. Transplantation, 2014, Sep-27, Volume: 98, Issue:6 Topics: Antibodies; Apoptosis; Boronic Acids; Bortezomib; Cell Membrane; Female; Graft Rejection; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lymphocytes; Male; Proteasome Inhibitors; Pyrazines; Retrospective Studies	2014
Efficacy of bortezomib for reducing donor-specific antibodies in children and adolescents on a steroid minimization regimen. Pediatric transplantation, 2014, Volume: 18, Issue:5 Topics: Adolescent; Antibodies; Antibodies, Monoclonal, Murine-Derived; Boronic Acids; Bortezomib; Child; Child, Preschool; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunosuppressive Agents; Isoantibodies; Kidney Failure, Chronic; Kidney Transplantation; Male; Methylprednisolone; Plasmapheresis; Pyrazines; Retrospective Studies; Rituximab; Steroids; Tissue Donors; Treatment Outcome; Young Adult	2014
Extended high cut-off haemodialysis for myeloma cast nephropathy in Auckland, 2008-2012. Nephrology (Carlton, Vic.), 2014, Volume: 19, Issue:7 Topics: Aged; Antineoplastic Agents; Antineoplastic Protocols; Biopsy; Boronic Acids; Bortezomib; Dexamethasone; Female; Humans; Immunoglobulin Light Chains; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Leukemia, Plasma Cell; Male; Middle Aged; Multiple Myeloma; New Zealand; Pyrazines; Remission Induction; Renal Dialysis; Thalidomide; Treatment Outcome	2014
Treatment strategies to treat antibody-mediated rejection and to reduce donor-specific antibodies. Pediatric transplantation, 2014, Volume: 18, Issue:5 Topics: Antibodies; Boronic Acids; Bortezomib; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Pyrazines; Steroids	2014
Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure. Bone marrow transplantation, 2014, Volume: 49, Issue:11 Topics: Adult; Aged; Antineoplastic Agents; Autografts; Boronic Acids; Bortezomib; Disease-Free Survival; Humans; Kidney Failure, Chronic; Male; Middle Aged; Multiple Myeloma; Pyrazines; Renal Dialysis; Retrospective Studies; Stem Cell Transplantation; Transplantation Conditioning	2014
The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation. Yonsei medical journal, 2015, Volume: 56, Issue:6 Topics: Adolescent; Adult; Antibodies, Monoclonal; Antineoplastic Agents; Boronic Acids; Bortezomib; Female; Graft Rejection; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Isoantibodies; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Plasmapheresis; Pyrazines; Transplantation, Homologous	2015
Bortezomib-based therapy as induction regimen of an autograft program in front-line treatment of multiple myeloma with end-stage renal disease. Annals of hematology, 2010, Volume: 89, Issue:8 Topics: Adult; Antineoplastic Agents; Boronic Acids; Bortezomib; Humans; Kidney Failure, Chronic; Male; Middle Aged; Multiple Myeloma; Pyrazines; Treatment Outcome	2010
Bortezomib successfully reverses early recurrence of light-chain deposition disease in a renal allograft: a case report. Transplantation proceedings, 2009, Volume: 41, Issue:10 Topics: Adult; Antilymphocyte Serum; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Melphalan; Multiple Myeloma; Paraproteinemias; Pyrazines; Recurrence; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome	2009
Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection. Transplantation, 2010, Feb-15, Volume: 89, Issue:3 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Biopsy; Boronic Acids; Bortezomib; Creatinine; Female; Graft Rejection; HLA Antigens; Humans; Immunologic Factors; Immunosuppression Therapy; Isoantibodies; Kidney Failure, Chronic; Kidney Transplantation; Protease Inhibitors; Pyrazines; Rituximab; Transplantation, Homologous; Young Adult	2010
Bortezomib in kidney transplant desensitization: a case report. Clinical transplants, 2009 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; B-Lymphocytes; Boronic Acids; Bortezomib; CD4-Positive T-Lymphocytes; Desensitization, Immunologic; Histocompatibility Testing; HLA-A Antigens; Humans; Immunologic Factors; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Mycophenolic Acid; Pyrazines; Rituximab; Waiting Lists	2009
Case presentations on two patients who received bortezomib for antibody mediated rejection at BIDMC. Clinical transplants, 2009 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Boronic Acids; Bortezomib; Creatinine; Female; Graft Rejection; HLA Antigens; HLA-DQ Antigens; Humans; Immunity, Cellular; Immunity, Humoral; Immunologic Factors; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Peritoneal Dialysis; Plasmapheresis; Polycystic Kidney Diseases; Protease Inhibitors; Pyrazines; Renal Dialysis; Reoperation; Rituximab; Treatment Failure	2009
Bortezomib in the treatment of antibody-mediated rejection--a report of 3 cases. Clinical transplants, 2009 Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Boronic Acids; Bortezomib; Female; Graft Rejection; Histocompatibility Testing; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Plasma Exchange; Protease Inhibitors; Pyrazines; Rituximab; Treatment Outcome	2009
The fate of anti-HLA antibody among renal transplantation recipients treated with bortezomib. Clinical transplants, 2009 Topics: Adult; Autoantibodies; Boronic Acids; Bortezomib; Cadaver; Creatinine; Female; Histocompatibility Antigens Class I; HLA Antigens; HLA-D Antigens; HLA-DQ Antigens; Humans; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Male; Middle Aged; Protease Inhibitors; Pyrazines; Tissue Donors	2009
Bortezomib for the treatment of de novo HLA antibody-related antibody mediated rejection. Clinical transplants, 2009 Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Boronic Acids; Bortezomib; Graft Rejection; HLA Antigens; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Plasmapheresis; Protease Inhibitors; Pyrazines; Rituximab	2009
Bortezomib as therapy for mixed humoral and cellular rejection: should it be first line? Clinical transplants, 2009 Topics: B-Lymphocytes; Boronic Acids; Bortezomib; Creatinine; Follow-Up Studies; Graft Rejection; Hepatitis C; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulins, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Protease Inhibitors; Pyrazines; T-Lymphocytes	2009
Bortezomib rescue in refractory acute humoral rejection--report of a case. Clinical transplants, 2009 Topics: Acute Disease; Boronic Acids; Bortezomib; Creatinine; Female; Graft Rejection; Histocompatibility Antigens Class I; HLA-D Antigens; Humans; Immunity, Humoral; Immunoglobulins, Intravenous; Immunologic Factors; Isoantibodies; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Plasmapheresis; Protease Inhibitors; Pyrazines	2009
Bortezomib successfully reduces monoclonal serum free light chain levels in a patient with recurrent myeloma and cast nephropathy in the renal transplant. Clinical transplants, 2009 Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Biopsy; Bone Marrow; Boronic Acids; Bortezomib; Female; Humans; Immunoglobulin kappa-Chains; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Multiple Myeloma; Mycophenolic Acid; Protease Inhibitors; Pyrazines; Recurrence; Syndecan-1; Tacrolimus	2009
Rescue therapy for early antibody mediated rejection with a proteasome inhibitor: a case report. Clinical transplants, 2009 Topics: Adult; Antilymphocyte Serum; Boronic Acids; Bortezomib; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diuresis; Graft Rejection; Histocompatibility Testing; HLA Antigens; Humans; Isoantibodies; Kidney Failure, Chronic; Kidney Transplantation; Male; Pancreas Transplantation; Plasmapheresis; Protease Inhibitors; Pyrazines; Renal Dialysis; Reoperation; Tissue Donors; Treatment Outcome	2009
Bortezomib does not reduce ABO-isoagglutinin titers and may not be useful for ABO-incompatible transplant desensitization. Clinical transplants, 2009 Topics: ABO Blood-Group System; Antiviral Agents; Blood Group Incompatibility; Boronic Acids; Bortezomib; Cytomegalovirus Infections; Doxorubicin; Ganciclovir; Hemagglutinins; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Multiple Myeloma; Protease Inhibitors; Pyrazines; Valganciclovir	2009
Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without vascular access. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2010, Volume: 10, Issue:9 Topics: Adult; Antibodies; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD20; Boronic Acids; Bortezomib; Catheters, Indwelling; Creatinine; Desensitization, Immunologic; Drainage; Drug Therapy, Combination; Female; Femoral Vein; Humans; Iliac Vein; Immunoglobulins, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Plasmapheresis; Protease Inhibitors; Pyrazines; Splanchnic Circulation; Therapies, Investigational; Tissue and Organ Procurement; Vena Cava, Inferior; Vena Cava, Superior; Venous Thrombosis	2010
Induction treatment of light chain deposition disease with bortezomib: rapid hematological response with persistence of renal involvement. Leukemia & lymphoma, 2012, Volume: 53, Issue:2 Topics: Adult; Antineoplastic Agents; Boronic Acids; Bortezomib; Humans; Kidney Failure, Chronic; Male; Middle Aged; Multiple Myeloma; Prognosis; Proteinuria; Pyrazines; Remission Induction	2012
Managing light chain deposition disease. Leukemia & lymphoma, 2012, Volume: 53, Issue:2 Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Humans; Kidney Failure, Chronic; Male; Multiple Myeloma; Pyrazines	2012
Effects of DPP-4 inhibitors on the heart in a rat model of uremic cardiomyopathy. PloS one, 2011, Volume: 6, Issue:11 Topics: Animals; Area Under Curve; Cardiomyopathies; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Gene Expression Regulation; Glomerular Filtration Rate; Glucagon-Like Peptide 1; Heart; Humans; Kidney Failure, Chronic; Linagliptin; Myocardium; Natriuretic Peptide, Brain; Nephrectomy; Piperidines; Purines; Pyrazines; Quinazolines; Rats; Reverse Transcriptase Polymerase Chain Reaction; Sitagliptin Phosphate; Triazoles; Uracil; Uremia	2011
High immunologic risk living donor kidney transplant using bortezomib in a novel induction regimen without acute antibody mediated rejection. Clinical transplants, 2011 Topics: Adult; Biopsy; Boronic Acids; Bortezomib; Desensitization, Immunologic; Fatal Outcome; Female; Graft Rejection; Graft Survival; Histocompatibility; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Isoantibodies; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Male; Monitoring, Immunologic; Phlebography; Pyrazines; Risk Assessment; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome	2011
[Nephropathy and metabolic heart diseases. Cardiac risk in kidney malfunction]. MMW Fortschritte der Medizin, 2012, Aug-23, Volume: 154, Issue:14 Topics: Cardiovascular Diseases; Cause of Death; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Humans; Kidney Failure, Chronic; Metabolic Syndrome; Pyrazines; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors; Sitagliptin Phosphate; Survival Rate; Triazoles	2012
Amiloride treatment in patients with potassium-losing nephropathy. Danish medical bulletin, 1981, Volume: 28, Issue:5 Topics: Aged; Amiloride; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Potassium; Pyrazines	1981
Mechanism of potassium secretion in chronic renal failure studied by means of amiloride. Medicina, 1981, Volume: 41, Issue:4 Topics: Amiloride; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Kidney Tubules, Distal; Nephrons; Potassium; Pyrazines; Sodium	1981
Amiloride handling in renal failure. British journal of clinical pharmacology, 1980, Volume: 9, Issue:1 Topics: Adult; Aged; Amiloride; Feces; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Pyrazines	1980
Uric acid and the kidney. Perspectives in nephrology and hypertension, 1976, Volume: 3 Topics: Acute Kidney Injury; Ammonia; Animals; Glomerular Filtration Rate; Glutamine; Gout; Humans; Hydrogen-Ion Concentration; Kidney; Kidney Calculi; Kidney Diseases; Kidney Failure, Chronic; Kidney Tubules; Metabolic Diseases; Pyrazines; Uric Acid	1976
Limitation on the use of amiloride in early renal failure. European journal of clinical pharmacology, 1985, Volume: 28, Issue:1 Topics: Adult; Aged; Amiloride; Calcium; Female; Humans; Kidney Failure, Chronic; Kinetics; Magnesium; Male; Middle Aged; Potassium; Pyrazines; Sodium; Spectrometry, Fluorescence; Time Factors	1985
Effect of amiloride hydrochloride (MK-870) in patients with cirrhosis. The Johns Hopkins medical journal, 1969, Volume: 125, Issue:2 Topics: Diuretics; Edema; Humans; Hypokalemia; Kidney Failure, Chronic; Liver Cirrhosis; Natriuresis; Potassium; Pyrazines	1969